An Endogenous Biomarker for Predicting OATP1B DDIs
This blog reviews the role of the endogenous biomarker, CP-1, for assessing OATP1B transporter-mediated drug-drug…
CertaraApril 5, 2024
Optimizing the Quality of CDISC SDTM Compliance [APAC Webinar]
Since the FDA passed regulations requiring submitted datasets to be compliant with the CDISC Study…
CertaraApril 2, 2024
What’s Driving the Increased Demand for SEND Dataset Services?
Gain an understanding of CDISC SEND dataset creation challenges impacting the biopharma industry, and how…
CertaraMarch 29, 2024
Closing the Loop: How to Improve the Management of Your Design-Make-Test-Analyze Cycle
Scientists in drug discovery often spend excessive time managing research data instead of concentrating on…
CertaraMarch 28, 2024
Certara.AI
Learn more about Certara.AI Transcript: Did you know that eighty percent of life sciences…
CertaraMarch 28, 2024
Certara Talks: PHUSE 2024 Recap
In this episode of Certara Talks, Jeff Abolafia, Kristin Kelly, and Julie Ann Hood recap…
CertaraMarch 27, 2024
Precision Predictions: Simcyp™ Simulator for Kinase Inhibitors
Download the Scientific Brief Transcript:In pharmaceutical research and development, R&D, companies utilize biosimulation and…
CertaraMarch 27, 2024
How to Avoid & Fix Common Mistakes in Regulatory Submissions
Learn how to avoid common mistakes so you can streamline your submission process, maximize your…
CertaraMarch 26, 2024
